Skip to main content
AimwellBio · Decision Intelligence
Platform Platform How It Works All Solutions Methodology See It Live →
Member Products AIMN:VERDICT FHIN Network Reserve Founding seat →
Built for biopharma decisions. About Security & Compliance Case Studies Intelligence Briefings Press & Media
Investors
Join the intelligence network FHIN Contributor Network Browse Contributors Become a Contributor For Practitioners
Pricing Client Login Start Simple Newsroom
Request Access
FHIN Contributor Network

This is not for pharma buyers.
This is for domain experts.

FHIN contributors are the verification layer beneath AimwellBio's intelligence platform. They are credentialed professionals — clinicians, regulatory scientists, HEOR specialists, researchers — who contribute structured, anonymized expert input to help audit AI-generated biopharma intelligence before it reaches decision makers.

Who Should Apply
Clinical & Medical

Physicians, pharmacists, clinical researchers, and trial investigators with hands-on experience evaluating therapeutic evidence and treatment protocols.

Regulatory & Compliance

Regulatory affairs professionals, former FDA/EMA reviewers, and compliance specialists who understand filing pathways, guidance documents, and approval timelines.

HEOR & Market Access

Health economists, outcomes researchers, and payer access specialists with experience building or challenging cost-effectiveness models and reimbursement strategies.

Not sure?

If your work involves evaluating medical or regulatory evidence for biopharma decisions, you are likely eligible. Apply as an Observer first — FHIN access follows credential verification.

Start as Observer →
What You May Contribute
  • ✓Structured responses to evidence-quality prompts in your domain — clinical, regulatory, or HEOR
  • ✓Assessments of AI-generated biopharma briefs flagged for adversarial review
  • ✓Signal validation: confirming, challenging, or contextualizing data points from primary sources
  • ✓All contributions are anonymized and aggregated before any output is generated — you are never individually attributed in any intelligence product
What You May Receive
  • ✓A verified contributor profile on AimwellBio — a credential you can share with your network
  • ✓Access to intelligence outputs from the FHIN network — briefings not available to general Observer tier
  • ✓Compensation for validated contributions — structure varies by engagement type and is disclosed before any contribution is requested
  • ✓Early access to new intelligence verticals as they open — FHIN contributors are the first to see new therapeutic areas before Observer release
The Contributor Status Ladder

Contributor standing is earned in steps, not bought. Here is the path and what each step unlocks today — and what is still activating.

01
Observer — you enter the network

Create an account and read evidence-backed verdicts. Atlas access and the vault are active now. This is where everyone starts.

02
Contributor — your credential is reviewed

Apply with your professional credentials. After review you receive a contributor profile page you can share with your network, and you contribute structured, anonymized expert input. Credential checks (NPI, ORCID) are pending — we do not display a verification badge until those public registries clear.

03
Signal & Shield — you unlock the intelligence layer

Contributors can move up to Signal or Shield for the working intelligence layer. The signal feed, alerts, watchlist, and dossiers are activating during onboarding — not switched on yet. Sample briefs are labeled Sample so you always know what is real.

04
Command — institutional standing

The institutional tier is sales-assisted — we scope it with you directly rather than a self-serve checkout.

Talk to us about Command →
What an Earned Profile Looks Like

A complete contributor profile carries your credentials, focus areas, and the work you choose to highlight. See the standard a finished profile sets — then build yours toward it.

View the standard profile →
Ask a Contributor

Every contributor profile carries a collaboration request affordance. You write the question; we route it to the contributor through our team. This is a request, not a chat — we do not promise a response time, and a contributor is always free to decline. That is by design: it keeps the channel respectful of their time.

Browse contributors to ask →
Ready to apply as a FHIN contributor?

Applications are reviewed individually. Start with Observer access — FHIN invitations follow credential verification.

Start as Observer → Questions →

Request Collaboration

Request sent
We'll route your request within 48 hours.

AimwellBio

Private intelligence infrastructure for biopharmaceutical organizations. Continuous monitoring, hallucination containment, and decision-ready executive outputs.

Product

Platform AIMN:VERDICT Signals Methodology

Network

FHIN Community Professionals Request Access

Company

About Security Privacy Terms
© 2026 Aimwell Partners Inc. All rights reserved.
Privacy PolicyTerms of UseData UseRequest Access
AimwellBio provides analytical and informational outputs to support organizational decision-making. It does not constitute medical advice, regulatory guidance, investment recommendations, or legal counsel. All intelligence outputs should be reviewed by qualified professionals before action is taken.